On July 2-5, Catholic University in Lyon, France, hosted the 17th World Congress of the International Pancreas and Islet Transplant Association. Nearly 350 attendees from over 30 countries and 5 continents discussed the latest developments in beta cell replacement to treat type 1 diabetes. It was an exciting time, as Southern France was in the midst of a record heatwave with temperatures to 45.9˚C, IPITA shared Lyon’s international stage with the FIFA Women’s World Cup semifinals in which the US team prevailed over a spirited UK team.

The Congress began with a pre-meeting focused on follow-up of the consensus conference held by IPITA in Igls, Austria, in 2017 that established a paradigm to define post-transplant beta cell function; such criteria have long been lacking in the field and will facilitate scientific comparison of outcomes of various approaches to beta cell replacement. The meeting proper centered on advances in pancreas and islet transplantation as well as new developments in artificial pancreas, stem cells and beta cells, xeno-islets and blastocyst complementation to generate human organs in animal hosts.

Several highlights from the meeting merit specific mention. First is the fine work of the Young Investigators Committee (YIC) which not only developed and ran an excellent pre-meeting pancreas recovery simulation session, but also orchestrated the “Cavemen versus Dinosaurs” debate forum during which the YIC Cavemen challenged long-held dogma about pancreas and islet transplantation that the more mature Dinosaurs tried to defend; it was an epic battle in which both sides claimed victory.

Second, there was clear evidence presented of improved results for both isolated islet and whole organ pancreas transplant. The value of these options was poignantly illustrated in testimonials by type 1 patients during two plenary sessions about living with T1D and the impact of a cure. Most exciting though may the report of plans for the first non-encapsulated trial of porcine islets with clinically relevant immunosuppression, and the critical mass of academic and industry teams progressing toward clinical evaluation of stem cell derived islets.

Please join IPITA to continue these discussions at the Third Opinion Leaders meeting on Stem Cell Derived Beta Cells on April 21-22, 2020 in Boston, MA, at the Martin Conference Center at Harvard Medical School. And, we look forward to seeing substantive additional progress over the next two years when we convene the tri-partite meeting of IPITA, IXA, and CTRMS to be held October 20-25 in 2021 San Diego, California.

Finally, on behalf of the Association, we wish to thank Dr. Thierry Berney for his strong and able leadership as IPITA President over the past two years.  

IPITA 2019 Award Winners

IPITA Young Investigator Awards

  • Antonio Citro
    San Raffaele Institute, Milan, Italy
    Bioengineering of an iPSC Derived Vascularized Endocrine Organ for T1D
  • Michiel Nijhoff
    Leiden University Medical Center, Leiden, The Netherlands
    Long-Term Outcomes of Pancreas-After-Kidney and Islet-after-Kidney Transplantation
  • Silvia Pellegrini
    San Raffaele Institute, Milan, Italy
    Insulin Producing Cells Derived from Induced Pluripotent Stem Cells (Ipsc): A Comparison with Human Islets
  • Prathab Saravanan
    Baylor transplant Institute, Dallas, USA
    Withaferin A Attenuates Release of Exosomal Isletokines in Response to Islet ER Stress
  • Riccardo Tamburrini
    Wake Forest, Winston Salem, USA
    Novel Water-based, Detergent-free Decellularization to Produce Bioactive ECM-based Scaffolds for Pancreatic Islets Transplantation
  • Nathan Zammit
    Garvan Institute, Sydney, Australia
    Optimisation of an Adeno-Associated Virus Gene Delivery into Neonatal Porcine Islets

TTS Young Investigator Awards

  • Ibrahim Fathi
    Tohoku University, Sendai, Japan
    Krp-203 as a Desirable Immunomodulator for Islet Transplantation
  • Austin Feeney
    University of Wisconsin, Madison, USA
    BMI is not Universally Predictive of Pancreas and Islet Lipid Content
  • Fanny Lebreton
    University of Geneva, Geneva, Switzerland
    Shielding Islets with Human Amniotic Epithelial Cells Protects Islets Against Hypoxia and Enhances Islet Engraftment and Revascularization after Transplantation in a Murin Diabetic Model
  • Daniel Tremmel
    University of Wisconsin, Madison, USA
    Reconstructing the In Vivo Niche for Improved Islet Culture and Transplantation
  • Charles-Henri Wassmer
    University of Geneva, Geneva, Switzerland
    Assessment of Insulin Sensitivity in Pancreas and Islet Transplant Recipients



Staff Directory
+1-514-874-1717, X : 216


International Pancreas & Islet Transplant Association
International Headquarters
505 Boulevard René-Lévesque Ouest
Suite 1401
Montréal, QC, H2Z 1Y7